Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.
Saved in:
| Title: | Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells. |
|---|---|
| Authors: | Humar M; Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University of Freiburg , Freiburg , Germany., Azemar M; Internistische Onkologie, Tumor Biology Center , Freiburg , Germany., Maurer M; Basilea Pharmaceutica International Ltd. , Basel , Switzerland., Groner B; Institute for Biomedical Research, Georg Speyer Haus , Frankfurt am Main , Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2014 Oct 06; Vol. 4, pp. 270. Date of Electronic Publication: 2014 Oct 06 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2014.00270 |
